141 related items for PubMed ID: 9597670
1. Platelet 5-HT and plasma cortisol concentrations after dexamethasone suppression test in patients with different time course of schizophrenia.
Jakovljević M, Mück-Seler D, Pivac N, Crncević Z.
Neuropsychobiology; 1998; 37(3):142-5. PubMed ID: 9597670
[Abstract] [Full Text] [Related]
2. Platelet 5-HT levels and hypothalamic-pituitary-adrenal axis activity in schizophrenic patients with positive and negative symptoms.
Pivac N, Mück-Seler D, Jakovljević M.
Neuropsychobiology; 1997; 36(1):19-21. PubMed ID: 9211439
[Abstract] [Full Text] [Related]
3. Platelet serotonin, plasma cortisol, and dexamethasone suppression test in schizophrenic patients.
Mück-Seler D, Pivac N, Jakovljević M, Brzović Z.
Biol Psychiatry; 1999 Jun 01; 45(11):1433-9. PubMed ID: 10356625
[Abstract] [Full Text] [Related]
4. Dexamethasone suppression test in severe schizophrenic illness: effects of plasma dexamethasone and caffeine levels.
Holsboer-Trachsler E, Buol C, Wiedemann K, Holsboer F.
Acta Psychiatr Scand; 1987 Jun 01; 75(6):608-13. PubMed ID: 3618283
[Abstract] [Full Text] [Related]
5. Hypothalamic-pituitary-adrenal axis function and platelet serotonin concentrations in depressed patients.
Pivac N, Jakovljević M, Mück-Seler D, Brzović Z.
Psychiatry Res; 1997 Dec 05; 73(3):123-32. PubMed ID: 9481804
[Abstract] [Full Text] [Related]
6. Dexamethasone suppression test in schizophrenia: its relation to monoamine metabolism in hypothalamic-pituitary-adrenal axis.
Kaneko M, Murata S, Hoshino Y, Takahagi K, Yokoyama F, Watanabe M, Kumashiro H.
Neuropsychobiology; 1997 Dec 05; 24(1):12-6. PubMed ID: 2132636
[Abstract] [Full Text] [Related]
7. [Dexamethasone suppression test and the positive and negative symptoms of schizophrenia].
Rybakowski J, Linka M, Matkowski K, Kanarkowski R.
Psychiatr Pol; 1991 Dec 05; 25(5):9-15. PubMed ID: 1821997
[Abstract] [Full Text] [Related]
8. Monoamine oxidase and cortisol response in depression and schizophrenia.
Pandey GN, Sharma RP, Janicak PG, Davis JM.
Psychiatry Res; 1992 Oct 05; 44(1):1-8. PubMed ID: 1461943
[Abstract] [Full Text] [Related]
9. Dexamethasone suppression test in first-episode schizophrenia.
Cesková E, Kaspárek T, Zourková A, Prikryl R.
Neuro Endocrinol Lett; 2006 Aug 05; 27(4):433-7. PubMed ID: 16892008
[Abstract] [Full Text] [Related]
10. Hypothalamic-pituitary-adrenal axis function in chronic schizophrenia: association with clinical features.
Kaneko M, Yokoyama F, Hoshino Y, Takahagi K, Murata S, Watanabe M, Kumashiro H.
Neuropsychobiology; 1992 Aug 05; 25(1):1-7. PubMed ID: 1351264
[Abstract] [Full Text] [Related]
11. Dexamethasone suppression test in positive and negative schizophrenia.
Altamura C, Guercetti G, Percudani M.
Psychiatry Res; 1989 Oct 05; 30(1):69-75. PubMed ID: 2594873
[Abstract] [Full Text] [Related]
12. Serial dexamethasone suppression tests in psychiatric illness: Part I. A study in schizophrenia and mania.
Baumgartner A, Gräf KJ, Kürten I.
Psychiatry Res; 1986 May 05; 18(1):9-23. PubMed ID: 2874578
[Abstract] [Full Text] [Related]
13. Acute administration of buspirone increases the escape of hypothalamic-pituitary-adrenal-axis hormones from suppression by dexamethasone in depression.
Maes M, Van Gastel A, Meltzer HY, Cosyns P, Blockx P, Desnyder R.
Psychoneuroendocrinology; 1996 Jan 05; 21(1):67-81. PubMed ID: 8778905
[Abstract] [Full Text] [Related]
14. Cortisol and corticosterone response after syn-corticotropin in relationship to dexamethasone suppressibility of cortisol.
Gerken A, Holsboer F.
Psychoneuroendocrinology; 1986 Jan 05; 11(2):185-94. PubMed ID: 3018821
[Abstract] [Full Text] [Related]
15. Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response.
Poland RE, Rubin RT, Lesser IM, Lane LA, Hart PJ.
Arch Gen Psychiatry; 1987 Sep 05; 44(9):790-5. PubMed ID: 3632252
[Abstract] [Full Text] [Related]
16. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II.
Lammers CH, Garcia-Borreguero D, Schmider J, Gotthardt U, Dettling M, Holsboer F, Heuser IJ.
Biol Psychiatry; 1995 Dec 15; 38(12):803-7. PubMed ID: 8750038
[Abstract] [Full Text] [Related]
17. Hypothalamic-pituitary-adrenal-axis hyperactivity in bulimia.
Hudson JI, Pope HG, Jonas JM, Laffer PS, Hudson MS, Melby JC.
Psychiatry Res; 1983 Feb 15; 8(2):111-7. PubMed ID: 6574529
[Abstract] [Full Text] [Related]
18. Hypothalamic-pituitary-adrenal axis in corticosteroid-resistant bronchial asthma.
Lane SJ, Atkinson BA, Swaminathan R, Lee TH.
Am J Respir Crit Care Med; 1996 Feb 15; 153(2):557-60. PubMed ID: 8564097
[Abstract] [Full Text] [Related]
19. Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women.
Muck-Seler D, Pivac N, Mustapic M, Crncevic Z, Jakovljevic M, Sagud M.
Psychiatry Res; 2004 Jul 15; 127(3):217-26. PubMed ID: 15296821
[Abstract] [Full Text] [Related]
20. Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals.
Huizenga NA, Koper JW, de Lange P, Pols HA, Stolk RP, Grobbee DE, de Jong FH, Lamberts SW.
J Clin Endocrinol Metab; 1998 Jan 15; 83(1):47-54. PubMed ID: 9435415
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
